Genevoyager
PrivateLast Round
Series A
Sep 12, 2023
Total Funding Raised
$32.77M
Company Overview
Genevoyager is a biotechnology company that provides one-stop Contract Research, Development, and Manufacturing Organization (CRO/CDMO) services for gene therapy products, specializing in large-scale viral vector preparation and delivery technologies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genevoyager Comparables
Compare Genevoyager with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ascend | 83% | |
| uBriGene Biosciences | 82% | |
| PackGene Biotech | 82% |
Genevoyager Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 12, 2023 | ||||
| Series A | Aug 1, 2023 | ||||
| Pre Seed | Jun 1, 2022 |
Genevoyager Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hongxin Capital | Series A |
| SDIC Venture Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2022
$5.2M raised in Pre Seed round.
Genevoyager Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Genevoyager's valuation, stock price, and market status.
Is Genevoyager a public or private company?
Genevoyager is a private company.
What is the current stock price of Genevoyager?
Genevoyager is a private company with no public stock price. No recent secondary market data is available.
How much is Genevoyager worth (valuation)?
Valuation information for Genevoyager is not publicly available.
Can I buy Genevoyager stock?
Genevoyager shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Genevoyager's last funding round?
Genevoyager's most recent funding round was Series A on September 12, 2023.
Who are the main investors in Genevoyager?
Investor information for Genevoyager is not publicly disclosed.
Will Genevoyager IPO soon?
No public IPO plans have been announced for Genevoyager.
How can I track Genevoyager secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Genevoyager's secondary market activity and sign up for updates.